Tag: ai in biopharmaceuticals market drivers

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Does the Forecast Indicate for the Artificial Intelligence (AI) In Biopharmaceuticals Market From 2025 to 2029?

The market size for artificial intelligence (AI) in biopharmaceuticals has witnessed a rapid expansion in the preceding years. The market is projected to escalate from $1.59 billion in 2024 to $2.1 billion in 2025, representing a compound annual growth rate (CAGR) of 32.2%. This surge in the historical period is contributable to growth strides in computational prowess, an outburst of biomedical data, the paradigm of precision medicine, coupled with regulatory backing and guidance.

The AI in biopharmaceuticals sector is predicted to undergo extensive growth in the coming years, reaching a market size of $6.58 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 33.0%. This potential boost during the projected period is credited to the evolution in computational biology, the fusion of multiple types of data, the intersection of AI with life sciences, regulatory endorsements and structures, and the principles of unbiased and ethical AI. The forecast period will also witness several prime trends such as the incorporation of multi-omics data, AI-powered drug conception and discovery, interpretive AI and regulatory approval, technological progress, regulatory shifts, and budding opportunities.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14251&type=smp

What Elements Are Contributing To Growth In The Artificial Intelligence (AI) In Biopharmaceuticals Market?

The rise in chronic diseases is anticipated to fuel the expansion of the artificial intelligence (AI) in biopharmaceuticals market. Chronic illnesses are persisting conditions that usually advance gradually and can last for a number of years or even a lifetime. They are caused by lifestyle choices, an older demographic, hereditary factors, and environmental influences. AI in biopharmaceuticals is being increasingly utilized for the management of chronic illnesses due its capacity to process vast amounts of varied data sources, spot patterns, and customize treatment plans. For example, the Department of Health and Human Services reported in November 2023 that there was an 11 percent increase in newly reported cases of chronic Hepatitis B in 2022 compared to 2021, demonstrating the escalating prevalence of chronic diseases. This rise in chronic diseases is therefore propelling the growth of the artificial intelligence (AI) in biopharmaceuticals market.

The artificial intelligence (ai) in biopharmaceuticals market covered in this report is segmented –

1) By Offering: Hardware, Software, Services

2) By Deployment: Cloud, On-Premises

3) By Technology: Machine Learning, Natural Language Processing, Deep Learning, Other Technologies

4) By Application: Business Process And Supply Chain, Drug Discovery, Medical Imaging And Diagnostics, Precision Medicine

5) By End-Users: Manufacturers, Contract Research Organizations, Academic And Government Research Institutes

Subsegments:

1) By Hardware: High-Performance Computing Systems, AI-Enabled Laboratory Equipment, Data Storage Solutions

2) By Software: Drug Discovery Platforms, Clinical Trial Management Software, Predictive Analytics Tools, Natural Language Processing Solutions

3) By Services: Consulting Services, Implementation And Integration Services, Data Management And Analytics Services, Training And Support Services

What Future Market Trends Are Projected For The Artificial Intelligence (AI) In Biopharmaceuticals Industry?

Top corporations in the biopharmaceutical AI sector are concentrating their efforts on the creation of groundbreaking advancements like AI-empowered solutions for target and lead identification suites, which can expedite the process of drug discovery and precision medicine, thereby revolutionizing life sciences organizations. These innovative strategies cover a range of methods for creating new drugs and customizing treatments for individual patients. For example, in May 2023, Google LLC, a US-based cloud computing services provider, rolled out two new AI tools named target and lead identification suites. These tools are designed to assist researchers in predicting and understanding protein structures, a key element in drug development. Furthermore, these suites will enable researchers to consume, store, analyze, and distribute large volumes of genomic data, a vital component in precision medicine. These tools aim to simplify the drug discovery procedures, decrease expenses, and speed up the time it takes to bring new treatments to the marketplace. The tools offer effective data management, precise predictions of protein structures, and sophisticated genomic analysis capabilities, aiming to overhaul the process of drug development and enhance patient outcomes.

Who Are The Key Contributors To Growth In The Artificial Intelligence (AI) In Biopharmaceuticals Market?

Major companies operating in the artificial intelligence (AI) in biopharmaceuticals market are Apple Inc., Google LLC, Microsoft Corporation, Tencent Holdings Limited, Amazon Web Services Inc., International Business Machines Corporation, Exscientia Limited, NVIDIA Corporation, Amgen Inc., DeepMind Technologies Limited, Schrödinger Inc., XtalPi Inc., ConcertAI Inc., Insilico Medicine Inc., Recursion Pharmaceuticals, BenevolentAI, BioXcel Therapeutics, Atomwise Inc., BioAge Labs Inc., GNS Healthcare, Berg Health, Deep 6 AI Inc., Cloud Pharmaceuticals Inc., Numerate Inc., AI Therapeutics, Envisagenics, twoXAR Inc., Cyclica Inc.

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-biopharmaceuticals-global-market-report

Which Region Is Projected To Lead The Artificial Intelligence (AI) In Biopharmaceuticals Market By 2025?

North America was the largest region in the artificial intelligence (AI) in biopharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in biopharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=14251&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What is the Anticipated CAGR of the Artificial Intelligence (AI) In Biopharmaceuticals Market, and What Factors Will Drive It?

The market size of artificial intelligence (AI) in biopharmaceuticals has experienced a tremendous increase recently. The projection is that it will rise from $1.59 billion in 2024 to $2.1 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 32.2%. The substantial expansion during the historical period can be linked to developments in computational capabilities, the surge of biomedical data, paradigm of precision medicine, as well as regulatory assistance and direction.

The market size for artificial intelligence (AI) in biopharmaceuticals is projected to witness a substantial increase in the forthcoming years, reaching $6.58 billion by 2029 with a compound annual growth rate (CAGR) of 33.0%. The expected expansion during the forecast period can be credited to advancements in computational biology, the harmonizing of multi-modal data, the meeting point of ai and life sciences, supportive regulatory frameworks, and just and ethical ai principles. Major trends anticipated during the forecast span include the unification of multi-omics data, drug design, and discovery driven by AI, understandable AI and regulatory approval, advancements in technology, evolutions in regulations, and burgeoning opportunities.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14251&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Artificial Intelligence (AI) In Biopharmaceuticals Market?

The escalating incidence of chronic diseases is anticipated to spur the expansion of the artificial intelligence (AI) in biopharmaceuticals market in the future. These long-term conditions progress at a slow rate and can endure for many years or even a person’s entire lifespan. They occur due to factors such as lifestyle choices, an aging populace, genetic tendencies, and environmental conditions. AI in biopharmaceuticals is now being increasingly employed to handle these chronic conditions as it can process large quantities of diverse data, detect patterns and customize treatment methods. For example, the Department of Health and Human Services reported in November 2023 that there was an 11 percent rise in new cases of chronic hepatitis B in the United States in 2022 compared to 2021. Consequently, the accelerating prevalence of chronic diseases is fueling the growth of the AI sector in the biopharmaceuticals market.

Which Key Market Segments Comprise the Artificial Intelligence (AI) In Biopharmaceuticals Market and Drive Its Revenue Growth?

The artificial intelligence (ai) in biopharmaceuticals market covered in this report is segmented –

1) By Offering: Hardware, Software, Services

2) By Deployment: Cloud, On-Premises

3) By Technology: Machine Learning, Natural Language Processing, Deep Learning, Other Technologies

4) By Application: Business Process And Supply Chain, Drug Discovery, Medical Imaging And Diagnostics, Precision Medicine

5) By End-Users: Manufacturers, Contract Research Organizations, Academic And Government Research Institutes

Subsegments:

1) By Hardware: High-Performance Computing Systems, AI-Enabled Laboratory Equipment, Data Storage Solutions

2) By Software: Drug Discovery Platforms, Clinical Trial Management Software, Predictive Analytics Tools, Natural Language Processing Solutions

3) By Services: Consulting Services, Implementation And Integration Services, Data Management And Analytics Services, Training And Support Services

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=14251&type=smp

Which Areas Are Leading Regions in the Artificial Intelligence (AI) In Biopharmaceuticals Market Expansion Across the Globe?

North America was the largest region in the artificial intelligence (AI) in biopharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in biopharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Key Market Trends in theArtificial Intelligence (AI) In Biopharmaceuticals Market Over the Coming Years?

Top-tier firms involved in the field of AI within biopharmaceuticals are prioritizing the creation of revolutionary improvements such as the target and lead identification suite AI-driven systems. These systems are aimed at speeding up the discovery of drugs and precision medicine, essentially changing the game within the field of life sciences. These tech-enabled improvements for the rapid discovery of drugs and precision medicine have a wide range of unique techniques for creating new drugs and personalizing therapy for patients. For example, Google LLC, an American-based cloud computing service provider, rolled out two new AI-driven tools – target and lead identification suites – in May 2023. These tools are meant to aid researchers in fortelling and comprehending protein structures, a vital aspect of drug creation. Additionally, this suite will assist researchers in absorbing, retaining, scrutinizing, and sharing vast amounts of genomic data, which is key to precision medicine. Moreover, these instruments aspire to simplify the drug discovery process, lessen expenses, and hasten the availability of new treatments in the market. By offering efficient data management, precise projections of protein structures, and superior genomic analysis capabilities, these tools hope to revolutionize drug development procedures and enhance patient outcomes.

View the full report here:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-biopharmaceuticals-global-market-report

How Is the Artificial Intelligence (AI) In Biopharmaceuticals Market Conceptually Defined?

Artificial intelligence (AI) in biopharmaceuticals refers to applying various AI techniques to analyze complex biological data and improve various aspects of drug discovery, development, and delivery within the pharmaceutical industry. AI in biopharmaceuticals holds great promise for revolutionizing drug discovery, development, and delivery processes by accelerating timelines, reducing costs, and improving the efficiency and effectiveness of treatments.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14251

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Artificial Intelligence (AI) In Biopharmaceuticals Market?

The market size of artificial intelligence (AI) in biopharmaceuticals has seen substantial growth in recent times. The size is projected to rise from $1.59 billion in 2024 to $2.12 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 33.1%. The growth witnessed in the historical period is mainly due to developments in computational ability, growth in biomedical data, shifts towards precision medicine, and regulatory guidance and support.

What Growth Rate Is Forecasted for the Artificial Intelligence (AI) In Biopharmaceuticals Market by 2029?

In the coming years, the market size for artificial intelligence (AI) in biopharmaceuticals is projected to experience significant expansion. The market is forecasted to increase to $6.67 billion in 2029, with a compound annual growth rate (CAGR) of 33.2%. This upward trend during the predicted period can be credited to the progress in computational biology, the integration of multi-modal data, the synergy between AI and life sciences, favorable regulatory environments, and the adoption of ethical AI principles. Key trends for the forecast period embrace the incorporation of multi-omics data, the use of AI in drug creation and discovery, the understanding and acceptance of AI in regulatory circles, technological progress, regulatory advancements, and fresh emerging opportunities.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14251&type=smp

Which Key Companies Are Shaping the Future of the Artificial Intelligence (AI) In Biopharmaceuticals Market?

Major companies operating in the artificial intelligence (AI) in biopharmaceuticals market are Apple Inc., Google LLC, Microsoft Corporation, Tencent Holdings Limited, Amazon Web Services Inc., International Business Machines Corporation, Exscientia Limited, NVIDIA Corporation, Amgen Inc., DeepMind Technologies Limited, Schrödinger Inc., XtalPi Inc., ConcertAI Inc., Insilico Medicine Inc., Recursion Pharmaceuticals, BenevolentAI, BioXcel Therapeutics, Atomwise Inc., BioAge Labs Inc., GNS Healthcare, Berg Health, Deep 6 AI Inc., Cloud Pharmaceuticals Inc., Numerate Inc., AI Therapeutics, Envisagenics, twoXAR Inc., Cyclica Inc.

Which Factors Are Driving Demand in the Artificial Intelligence (AI) In Biopharmaceuticals Industry?

The escalating occurrence of persistent illnesses is projected to stimulate the development of artificial intelligence (AI) in the biopharmaceuticals market. Chronic illnesses are enduring conditions that typically advance gradually and can last for several years or even a lifetime. The triggers primarily include lifestyle habits, an elderly population, genetic factors, and environmental elements. AI used in biopharmaceuticals is progressively being employed to control chronic diseases since it is capable of analyzing vast quantities of varied data, pinpointing patterns, and customizing treatment strategies. A case in point, in November 2023, the Department of Health and Human Services, a US government department, reported an increase of 11 percent in new cases of chronic hepatitis B in 2022 compared to 2021. Hence, the escalating occurrence of chronic diseases is fueling the growth of artificial intelligence (AI) in the biopharmaceuticals market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=14251&type=smp

How Is the Artificial Intelligence (AI) In Biopharmaceuticals Market Segmented by Several Divisions?

The artificial intelligence (AI) in biopharmaceuticals market covered in this report is segmented –

1) By Offering: Hardware, Software, Services

2) By Deployment: Cloud, On-Premises

3) By Technology: Machine Learning, Natural Language Processing, Deep Learning, Other Technologies

4) By Application: Business Process And Supply Chain, Drug Discovery, Medical Imaging And Diagnostics, Precision Medicine

5) By End-Users: Manufacturers, Contract Research Organizations, Academic And Government Research Institutes

Subsegments:

1) By Hardware: High-Performance Computing Systems, AI-Enabled Laboratory Equipment, Data Storage Solutions

2) By Software: Drug Discovery Platforms, Clinical Trial Management Software, Predictive Analytics Tools, Natural Language Processing Solutions

3) By Services: Consulting Services, Implementation And Integration Services, Data Management And Analytics Services, Training And Support Services

What are the Emerging Market Trends Driving the Growth of the Artificial Intelligence (AI) In Biopharmaceuticals Industry?

The primary focus for leading companies in the biopharmaceutical artificial intelligence (AI) industry is the creation of cutting-edge advancements such as the AI-powered solutions for target and lead identification suites. These are designed to expedite drug discovery processes and precision medicine, fundamentally reshaping life sciences organizations. These advancements, dedicated to drug discovery and precision medicine, provide an array of novel methodologies for developing new drugs and personalizing treatment plans. Google LLC, a US-based cloud computing service provider, launched two innovative AI-powered tools – the target and lead identification suites – in May 2023. These tools are designed to assist researchers in predicting and understanding protein structures, a fundamental aspect of drug creation. Additionally, this suite allows researchers to consume, stockpile, examine, and distribute vast amounts of genomic data, vital for precision medicine. These platforms intend to streamline drug discovery, cut down expenses, and expedite the delivery of new treatments to the market. By offering efficient data management, precise protein structure predictions, and progressive genomic analysis abilities, these tools aim to transform drug development processes and enhance patient outcomes.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-biopharmaceuticals-global-market-report

Which Regions Are Driving Growth in the Artificial Intelligence (AI) In Biopharmaceuticals Market?

North America was the largest region in the artificial intelligence (AI) in biopharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in biopharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14251

This Report Delivers Insight On:

1. How big is the artificial intelligence (ai) in biopharmaceuticals market, and how is it changing globally?

2. Who are the major companies in the artificial intelligence (ai) in biopharmaceuticals market, and how are they performing?

3. What are the key opportunities and risks in the artificial intelligence (ai) in biopharmaceuticals market right now?

4. Which products or customer segments are growing the most in the artificial intelligence (ai) in biopharmaceuticals market?

5. What factors are helping or slowing down the growth of the artificial intelligence (ai) in biopharmaceuticals market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the artificial intelligence (ai) in biopharmaceuticals industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Has The Artificial Intelligence (AI) In Biopharmaceuticals Market Growth Evolved From 2024 To 2025, And What’s Ahead?

The market size of artificial intelligence (AI) in biopharmaceuticals has seen a significant surge in the past years. It is forecasted to increase from $1.59 billion in 2024 to $2.12 billion in 2025, with a compound annual growth rate (CAGR) of 33.1%. The growth experienced during the historic period is credited to the progression in computational capabilities, a boom in biomedical data, the rise of precision medicine paradigm, as well as support and guidance from regulatory authorities.

Expectations are high for a significant expansion of the artificial intelligence (AI) in biopharmaceuticals market in the coming years. The market is predicted to reach $6.67 billion in 2029, reflecting a compound annual growth rate (CAGR) of 33.2%. This growth projection for the period is based on several factors, such as improvements in computational biology, multi-modal data integration, the merger of ai and life sciences, enhanced regulatory support and frameworks, and the adoption of principled AI. Key trends for the forecast period consist of the incorporation of multi-omics data, AI-enabled drug design and discovery, explainable AI and regulatory compliance, technological progression, regulatory advancements, and an array of emerging opportunities.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14251&type=smp

Which Factors and External Forces Are Driving Demand in the Artificial Intelligence (AI) In Biopharmaceuticals Market?

The surge in chronic illnesses is predicted to fuel the expansion of the artificial intelligence (AI) in the biopharmaceutical industry going forward. Chronic diseases, typically characterized by slow progression over years or potentially throughout an individual’s lifetime, are often resultant of lifestyle characteristics, an advancing aging demographic, genetic tendencies, and environmental contributors. AI, within the realm of biopharmaceuticals, has seen an upward trend in its usage for managing these chronic ailments, owing to its capacity to process large quantities of diverse data, spot trends and provide bespoke treatment plans. For example, the Department of Health and Human Services registered an 11 percent rise in newly reported chronic hepatitis B cases in November 2023, compared to 2021. Hence, the escalating occurrence of chronic diseases is propelling the growth of artificial intelligence (AI) in the biopharmaceutical sector.

Which Segments in the Artificial Intelligence (AI) In Biopharmaceuticals Offer the Most Growth?

The artificial intelligence (AI) in biopharmaceuticals market covered in this report is segmented –

1) By Offering: Hardware, Software, Services

2) By Deployment: Cloud, On-Premises

3) By Technology: Machine Learning, Natural Language Processing, Deep Learning, Other Technologies

4) By Application: Business Process And Supply Chain, Drug Discovery, Medical Imaging And Diagnostics, Precision Medicine

5) By End-Users: Manufacturers, Contract Research Organizations, Academic And Government Research Institutes

Subsegments:

1) By Hardware: High-Performance Computing Systems, AI-Enabled Laboratory Equipment, Data Storage Solutions

2) By Software: Drug Discovery Platforms, Clinical Trial Management Software, Predictive Analytics Tools, Natural Language Processing Solutions

3) By Services: Consulting Services, Implementation And Integration Services, Data Management And Analytics Services, Training And Support Services

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=14251&type=smp

What Are the Fastest-Growing Geographies in the Artificial Intelligence (AI) In Biopharmaceuticals Market?

North America was the largest region in the artificial intelligence (AI) in biopharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in biopharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Cutting-Edge Market Trends Are Expected to Drive the Artificial Intelligence (AI) In Biopharmaceuticals Market’s Growth?

Key players in the biopharmaceutical artificial intelligence (AI) sector are concentrating on creating pioneering advancements like AI-powered target and lead identification suite solutions to expedite the process of drug discovery and precision medicine. They are transforming life sciences firms with their groundbreaking methods for producing new drugs and customizing treatments for individual patients. For example, US-based cloud computing service provider Google LLC launched two AI-powered tools known as target and lead identification suites in May 2023, which are meant to assist researchers in predicting and understanding protein structures – a crucial aspect of drug development. Moreover, the suite will enable scientists to input, preserve, scrutinize, and disseminate large volumes of genomic data, which is essential for precision medicine. These tools aim to expedite the drug discovery process, cut costs, and accelerate the introduction of new treatments to the market. They offer efficient data management, precise predictions of protein structures, and superior genomic analysis abilities – hoping to revolutionize drug development processes and enhance patient results.

View the full report here:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-biopharmaceuticals-global-market-report

What Are the Key Elements That Define the Artificial Intelligence (AI) In Biopharmaceuticals Market?

Artificial intelligence (AI) in biopharmaceuticals refers to applying various AI techniques to analyze complex biological data and improve various aspects of drug discovery, development, and delivery within the pharmaceutical industry. AI in biopharmaceuticals holds great promise for revolutionizing drug discovery, development, and delivery processes by accelerating timelines, reducing costs, and improving the efficiency and effectiveness of treatments.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14251

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Drivers Are Shaping the Growth and Development of theArtificial Intelligence (AI) In Biopharmaceuticals Market?

The escalating incidences of chronic ailments are anticipated to drive the expansion of the artificial intelligence (AI) in biopharmaceuticals market in the future. Chronic diseases refer to long-term conditions that generally progress at a slow pace and could last for a prolonged number of years or even a lifetime. They stem from lifestyle factors, an aging demographic, genetic inclinations, and environmental influences. AI in biopharmaceuticals is increasingly utilized to handle chronic diseases since it assesses a vast amount of varied data sources, recognizes patterns, and personalizes treatment methods. For example, the Department of Health and Human Services stated in November 2023 that there was an 11 percent rise in new chronic hepatitis B cases in 2022 compared to 2021. Therefore, the escalating incidences of chronic diseases enhances the growth of artificial intelligence (AI) in the biopharmaceuticals market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14251&type=smp

#What is the Growth Potential of the Artificial Intelligence (AI) In Biopharmaceuticals Market, and How Will It Perform by 2034?

Recent years have seen a significant expansion in the market size for artificial intelligence (AI) in biopharmaceuticals. The market is predicted to increase from $1.59 billion in 2024 to about $2.12 billion in 2025, reflecting a compound annual growth rate (CAGR) of 33.1%. This remarkable growth during the historical period can be ascribed to factors such as enhanced computational capacity, a surge in biomedical data, the precision medicine model, and regulatory backing and guidance.

The market size of artificial intelligence (AI) in the biopharmaceutical industry is predicted to witness immense growth in the upcoming years, escalating to a value of $6.67 billion by 2029 with a compound annual growth rate (CAGR) of 33.2%. This growth in the outlook period can be ascribed to enhancements in computational biology, the amalgamation of diversified data, the intersection of AI and life sciences, supportive regulatory frameworks, and principles of ethical and fair AI. The forecast period will see dominant trends like the integration of multi-omics data, AI-infused drug design and discovery, understandable AI and regulatory approval, advancements in technology, regulatory changes, and the advent of new opportunities.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14251

Which Cutting-Edge Market Trends Are Expected to Drive theArtificial Intelligence (AI) In Biopharmaceuticals Market’s Growth?

Leading companies involving in the biopharmaceutical sector of artificial intelligence (AI) are primarily focusing their attention on creating revolutionary enhancements such as AI-integrated solutions for target and lead identification to speed up precision medicine and drug discovery, consequently transforming organizations within the life sciences realm. These innovative solutions for precision medicine and drug discovery encompass multiple approaches towards generating new medications and personalizing treatments for individual patients. For instance, in May 2023, Google LLC, a renowned provider of cloud computing services based in the US, rolled out two new AI-integrated tools, namely target and lead identification suites. These tools are designed to aid researchers in prediction and understanding of protein structures, an indispensable part of drug development. Moreover, this suite will also assist researchers in the intake, storage, analysis, and sharing of large volumes of genomic data, which is vital for precision medicine. Therefore, these tools function with the objective to optimize the process of drug discovery, lower costs, and expedite the introduction of new treatments in the market. By delivering efficient management of data, accurate prediction of protein structures and enhanced capabilities for genomic analysis, these tools seek to revolutionize the process of drug development and consequently, improve patient results.

What Are the Leading Market Players Impacting theArtificial Intelligence (AI) In Biopharmaceuticals Market’s Growth Trend?

Major companies operating in the artificial intelligence (AI) in biopharmaceuticals market are Apple Inc., Google LLC, Microsoft Corporation, Tencent Holdings Limited, Amazon Web Services Inc., International Business Machines Corporation, Exscientia Limited, NVIDIA Corporation, Amgen Inc., DeepMind Technologies Limited, Schrödinger Inc., XtalPi Inc., ConcertAI Inc., Insilico Medicine Inc., Recursion Pharmaceuticals, BenevolentAI, BioXcel Therapeutics, Atomwise Inc., BioAge Labs Inc., GNS Healthcare, Berg Health, Deep 6 AI Inc., Cloud Pharmaceuticals Inc., Numerate Inc., AI Therapeutics, Envisagenics, twoXAR Inc., Cyclica Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-biopharmaceuticals-global-market-report

How Are the Key Segments of the Artificial Intelligence (AI) In Biopharmaceuticals Market Driving Opportunities and Innovations?

The artificial intelligence (AI) in biopharmaceuticals market covered in this report is segmented –

1) By Offering: Hardware, Software, Services

2) By Deployment: Cloud, On-Premises

3) By Technology: Machine Learning, Natural Language Processing, Deep Learning, Other Technologies

4) By Application: Business Process And Supply Chain, Drug Discovery, Medical Imaging And Diagnostics, Precision Medicine

5) By End-Users: Manufacturers, Contract Research Organizations, Academic And Government Research Institutes

Subsegments:

1) By Hardware: High-Performance Computing Systems, AI-Enabled Laboratory Equipment, Data Storage Solutions

2) By Software: Drug Discovery Platforms, Clinical Trial Management Software, Predictive Analytics Tools, Natural Language Processing Solutions

3) By Services: Consulting Services, Implementation And Integration Services, Data Management And Analytics Services, Training And Support Services

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=14251&type=smp

What Regions Are At the Forefront of #What Drivers Are Shaping the Growth and Development of theArtificial Intelligence (AI) In Biopharmaceuticals Market?# Market Expansion?

North America was the largest region in the artificial intelligence (AI) in biopharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in biopharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Artificial Intelligence (AI) In Biopharmaceuticals Market 2025, By The Business Research Company:

Artificial Intelligence in Healthcare Diagnosis Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-healthcare-diagnosis-global-market-report

Artificial Intelligence (AI) In Industrial Machinery Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-industrial-machinery-global-market-report

Artificial Intelligence (AI) in Operating Room Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-operating-room-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the artificial intelligence (ai) in biopharmaceuticals market size evolved in recent years?

The market for artificial intelligence (AI) within the biopharmaceutical sector has been experiencing rapid expansion recently. Projections indicate that it will increase from $1.59 billion in 2024 to $2.12 billion in 2025, boasting a compound annual growth rate (CAGR) of 33.1%. Several factors have contributed to the growth during the historical period, including advances in computational capacity, a surge in biomedical data, the rise of precision medicine, and supportive regulatory frameworks and guidelines.

What are the predictions for the artificial intelligence (ai) in biopharmaceuticals market size in the coming years?

Over the coming years, the market size of artificial intelligence (AI) in biopharmaceuticals is projected to experience rapid growth. By 2029, it is anticipated to reach $6.67 billion, with a compound annual growth rate (CAGR) of 33.2%. The projected growth in this period is due to various factors including advancements in computational biology, multi-modal data integration, the merging of AI with life sciences, as well as the presence of regulatory support and frameworks, and the principles of ethical and fair AI. The forecast period will see key trends such as the incorporation of multi-omics data, the use of AI to drive drug design and discovery, the explanation and acceptance of AI by regulators, technological progress, regulatory developments, and emergence of new opportunities.

Get your artificial intelligence (ai) in biopharmaceuticals market report here!

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-biopharmaceuticals-global-market-report

What key factors are fueling the growth of the artificial intelligence (ai) in biopharmaceuticals market?

The rise in chronic disease prevalence is anticipated to fuel the expansion of the artificial intelligence (AI) in biopharmaceuticals market. Chronic conditions are often long-standing diseases that progress at a slower rate and can remain for a significant period or even for the entire life of a patient. Such conditions usually stem from lifestyle habits, an aged population, genetic susceptibilities, and environmental influences. AI in biopharmaceuticals plays a prominent role in managing chronic sickness because it scrutinizes large amounts of data from various sources, distinguishes patterns, and customizes therapeutic strategies. To exemplify, the Department of Health and Human Services reported in November 2023 that there was an 11 percent rise in newly diagnosed chronic hepatitis B cases in 2022 as opposed to 2021. Hence, the escalating prevalence of chronic illnesses fosters the advancement of artificial intelligence (AI) in the biopharmaceuticals sector.

How is the global artificial intelligence (ai) in biopharmaceuticals market divided into key segments?

The artificial intelligence (AI) in biopharmaceuticals market covered in this report is segmented –

1) By Offering: Hardware, Software, Services

2) By Deployment: Cloud, On-Premises

3) By Technology: Machine Learning, Natural Language Processing, Deep Learning, Other Technologies

4) By Application: Business Process And Supply Chain, Drug Discovery, Medical Imaging And Diagnostics, Precision Medicine

5) By End-Users: Manufacturers, Contract Research Organizations, Academic And Government Research Institutes

Subsegments:

1) By Hardware: High-Performance Computing Systems, AI-Enabled Laboratory Equipment, Data Storage Solutions

2) By Software: Drug Discovery Platforms, Clinical Trial Management Software, Predictive Analytics Tools, Natural Language Processing Solutions

3) By Services: Consulting Services, Implementation And Integration Services, Data Management And Analytics Services, Training And Support Services

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14251&type=smp

Who are the key firms paving the way for growth in the artificial intelligence (ai) in biopharmaceuticals market?

Major companies operating in the artificial intelligence (AI) in biopharmaceuticals market are Apple Inc., Google LLC, Microsoft Corporation, Tencent Holdings Limited, Amazon Web Services Inc., International Business Machines Corporation, Exscientia Limited, NVIDIA Corporation, Amgen Inc., DeepMind Technologies Limited, Schrödinger Inc., XtalPi Inc., ConcertAI Inc., Insilico Medicine Inc., Recursion Pharmaceuticals, BenevolentAI, BioXcel Therapeutics, Atomwise Inc., BioAge Labs Inc., GNS Healthcare, Berg Health, Deep 6 AI Inc., Cloud Pharmaceuticals Inc., Numerate Inc., AI Therapeutics, Envisagenics, twoXAR Inc., Cyclica Inc.

Which trends are expected to transform the artificial intelligence (ai) in biopharmaceuticals market?

Leading corporations engaged in the field of artificial intelligence (AI) applied to biopharmaceuticals have a strategic focus on creating ground-breaking advancements such as AI-powered target and lead identification suites. These ground-breaking tools have the potential to expedite drug discovery processes and precision medicine, essentially transforming the modus operandi of life sciences organizations. Such AI-powered solutions involve numerous ingenious methodologies for the creation of new drugs and personalizing therapies for individual patients. For example, Google LLC, a US company specializing in cloud computing services, introduced two new innovative AI-powered tools named target and lead identification suites, in May 2023. These tools are developed to support researchers in predicting and deciphering protein structures, a key aspect of drug development. Moreover, these suites aid researchers in the efficient handling, study, and sharing of vast amounts of genomic data, a fundamental element of precision medicine. Furthermore, the tools intend to simplify the drug discovery process, minimize costs, and quicken the release of new treatments into the market. By delivering effective data management, precise predictions of protein structures, and sophisticated genomic analysis, these tools strive to revolutionize drug production processes whilst enhancing patient outcomes.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14251

What regions are contributing significantly to the growth of the artificial intelligence (ai) in biopharmaceuticals market?

North America was the largest region in the artificial intelligence (AI) in biopharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in biopharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Artificial Intelligence in Healthcare Diagnosis Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-healthcare-diagnosis-global-market-report

Artificial Intelligence (AI) In Industrial Machinery Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-industrial-machinery-global-market-report

Artificial Intelligence (AI) in Operating Room Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-operating-room-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the artificial intelligence (ai) in biopharmaceuticals market size evolved in recent years?

The market for artificial intelligence (AI) within the biopharmaceutical sector has been experiencing rapid expansion recently. Projections indicate that it will increase from $1.59 billion in 2024 to $2.12 billion in 2025, boasting a compound annual growth rate (CAGR) of 33.1%. Several factors have contributed to the growth during the historical period, including advances in computational capacity, a surge in biomedical data, the rise of precision medicine, and supportive regulatory frameworks and guidelines.

What are the predictions for the artificial intelligence (ai) in biopharmaceuticals market size in the coming years?

Over the coming years, the market size of artificial intelligence (AI) in biopharmaceuticals is projected to experience rapid growth. By 2029, it is anticipated to reach $6.67 billion, with a compound annual growth rate (CAGR) of 33.2%. The projected growth in this period is due to various factors including advancements in computational biology, multi-modal data integration, the merging of AI with life sciences, as well as the presence of regulatory support and frameworks, and the principles of ethical and fair AI. The forecast period will see key trends such as the incorporation of multi-omics data, the use of AI to drive drug design and discovery, the explanation and acceptance of AI by regulators, technological progress, regulatory developments, and emergence of new opportunities.

Get your artificial intelligence (ai) in biopharmaceuticals market report here!

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-biopharmaceuticals-global-market-report

What key factors are fueling the growth of the artificial intelligence (ai) in biopharmaceuticals market?

The rise in chronic disease prevalence is anticipated to fuel the expansion of the artificial intelligence (AI) in biopharmaceuticals market. Chronic conditions are often long-standing diseases that progress at a slower rate and can remain for a significant period or even for the entire life of a patient. Such conditions usually stem from lifestyle habits, an aged population, genetic susceptibilities, and environmental influences. AI in biopharmaceuticals plays a prominent role in managing chronic sickness because it scrutinizes large amounts of data from various sources, distinguishes patterns, and customizes therapeutic strategies. To exemplify, the Department of Health and Human Services reported in November 2023 that there was an 11 percent rise in newly diagnosed chronic hepatitis B cases in 2022 as opposed to 2021. Hence, the escalating prevalence of chronic illnesses fosters the advancement of artificial intelligence (AI) in the biopharmaceuticals sector.

How is the global artificial intelligence (ai) in biopharmaceuticals market divided into key segments?

The artificial intelligence (AI) in biopharmaceuticals market covered in this report is segmented –

1) By Offering: Hardware, Software, Services

2) By Deployment: Cloud, On-Premises

3) By Technology: Machine Learning, Natural Language Processing, Deep Learning, Other Technologies

4) By Application: Business Process And Supply Chain, Drug Discovery, Medical Imaging And Diagnostics, Precision Medicine

5) By End-Users: Manufacturers, Contract Research Organizations, Academic And Government Research Institutes

Subsegments:

1) By Hardware: High-Performance Computing Systems, AI-Enabled Laboratory Equipment, Data Storage Solutions

2) By Software: Drug Discovery Platforms, Clinical Trial Management Software, Predictive Analytics Tools, Natural Language Processing Solutions

3) By Services: Consulting Services, Implementation And Integration Services, Data Management And Analytics Services, Training And Support Services

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14251&type=smp

Who are the key firms paving the way for growth in the artificial intelligence (ai) in biopharmaceuticals market?

Major companies operating in the artificial intelligence (AI) in biopharmaceuticals market are Apple Inc., Google LLC, Microsoft Corporation, Tencent Holdings Limited, Amazon Web Services Inc., International Business Machines Corporation, Exscientia Limited, NVIDIA Corporation, Amgen Inc., DeepMind Technologies Limited, Schrödinger Inc., XtalPi Inc., ConcertAI Inc., Insilico Medicine Inc., Recursion Pharmaceuticals, BenevolentAI, BioXcel Therapeutics, Atomwise Inc., BioAge Labs Inc., GNS Healthcare, Berg Health, Deep 6 AI Inc., Cloud Pharmaceuticals Inc., Numerate Inc., AI Therapeutics, Envisagenics, twoXAR Inc., Cyclica Inc.

Which trends are expected to transform the artificial intelligence (ai) in biopharmaceuticals market?

Leading corporations engaged in the field of artificial intelligence (AI) applied to biopharmaceuticals have a strategic focus on creating ground-breaking advancements such as AI-powered target and lead identification suites. These ground-breaking tools have the potential to expedite drug discovery processes and precision medicine, essentially transforming the modus operandi of life sciences organizations. Such AI-powered solutions involve numerous ingenious methodologies for the creation of new drugs and personalizing therapies for individual patients. For example, Google LLC, a US company specializing in cloud computing services, introduced two new innovative AI-powered tools named target and lead identification suites, in May 2023. These tools are developed to support researchers in predicting and deciphering protein structures, a key aspect of drug development. Moreover, these suites aid researchers in the efficient handling, study, and sharing of vast amounts of genomic data, a fundamental element of precision medicine. Furthermore, the tools intend to simplify the drug discovery process, minimize costs, and quicken the release of new treatments into the market. By delivering effective data management, precise predictions of protein structures, and sophisticated genomic analysis, these tools strive to revolutionize drug production processes whilst enhancing patient outcomes.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14251

What regions are contributing significantly to the growth of the artificial intelligence (ai) in biopharmaceuticals market?

North America was the largest region in the artificial intelligence (AI) in biopharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in biopharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Artificial Intelligence in Healthcare Diagnosis Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-healthcare-diagnosis-global-market-report

Artificial Intelligence (AI) In Industrial Machinery Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-industrial-machinery-global-market-report

Artificial Intelligence (AI) in Operating Room Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-operating-room-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How Will the Artificial Intelligence (AI) In Biopharmaceuticals Market Grow Over the Forecast Period Based on Its Expected CAGR?

The growth of the artificial intelligence (AI) in the biopharmaceutical market has surged immensely in recent years. It is projected to expand from $1.59 billion in 2024, to a substantial $2.12 billion in 2025, marking a compound annual growth rate (CAGR) of 33.1%. Factors such as advancements in computational capacity, the surge of biomedical data, the paradigm of precision medicine, and regulatory guidance and support contribute to the growth observed in the historic period.

Over the coming years, the market size for artificial intelligence (AI) in biopharmaceuticals is projected to expand significantly, estimated to reach a value of $6.67 billion in 2029, growing at a compound annual growth rate (CAGR) of 33.2%. This anticipated growth echos the progress in computational biology, the blend of multi-modal data, the confluence of AI and life sciences, as well as regulatory support and frameworks, together with ethical and equal AI principles. The forecast period is anticipated to observe key trends like multi-omics data integration, AI-driven methods in drug design and discovery, explainable AI gaining regulatory acceptance, technological advancements, regulatory developments, and newly emerging opportunities.

What External and Internal Drivers Are Contributing to the Growth of the artificial intelligence (ai) in biopharmaceuticals Market’s Growth?

The biopharmaceuticals market’s growth is set to be bolstered by the rising incidences of chronic diseases, which necessitate the expanded use of artificial intelligence (AI). Characterized by slow progression over many years or potentially a lifetime, chronic diseases emerge from various factors such as genetics, lifestyle, environmental triggers, and an aging populace. AI’s role in biopharmaceuticals is becoming more prominent, with its ability to process large quantities of varied data, discern patterns, and tailor treatment strategies. As proof, the Department of Health and Human Services, a United States governmental department, reported in November 2023 that newly reported cases of chronic hepatitis B had risen by 11 percent in 2022, compared to 2021. Consequently, the escalating occurrences of chronic diseases are fueling the demand for AI applications in the biopharmaceuticals market.

Get Your Free Sample of the Global Artificial Intelligence (AI) In Biopharmaceuticals Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=14251&type=smp

Who Are the Dominant Players Expanding Their Reach in the Artificial Intelligence (AI) In Biopharmaceuticals Market?

Major companies operating in the artificial intelligence (AI) in biopharmaceuticals market are:

• Apple Inc._x000D_

• Google LLC_x000D_

• Microsoft Corporation_x000D_

• Tencent Holdings Limited_x000D_

• Amazon Web Services Inc._x000D_

What Are the Top Trends Shaping the Evolution of the Artificial Intelligence (AI) In Biopharmaceuticals Market?

Leading firms operating in the biopharmaceutical artificial intelligence (AI) sector are prioritizing the development of groundbreaking innovations such as AI-guided solutions for target and lead identification, to expedite the drug discovery process and precision medicine, thereby revolutionizing life sciences organizations. This range of solutions includes several novel methods for creating new pharmaceuticals and personalizing treatment plans for each patient. For example, in May 2023, US-based cloud computing services provider, Google LLC, introduced two novel AI-supported tools named target and lead identification suites. These were devised to assist researchers in predicting and comprehending protein structures, a critical aspect of drug development. Furthermore, these suites would enable researchers to digest, save, examine, and distribute vast quantities of genomic data, an essential factor for precision medicine. The objective of these tools is to simplify the drug discovery procedure, lower expenses, and accelerate the introduction of new therapies to the market. By offering proficient data management, precise protein structure forecasting, and cutting-edge genomic examination abilities, these tools strive to transform drug development methods and enhance patient outcomes.

Get Instant Access to the Global Artificial Intelligence (AI) In Biopharmaceuticals Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-biopharmaceuticals-global-market-report

Which Growth-Oriented Segments of the Artificial Intelligence (AI) In Biopharmaceuticals Market Are Leading the Industry’s Development?

The artificial intelligence (AI) in biopharmaceuticals market covered in this report is segmented –

1) By Offering: Hardware, Software, Services

2) By Deployment: Cloud, On-Premises

3) By Technology: Machine Learning, Natural Language Processing, Deep Learning, Other Technologies

4) By Application: Business Process And Supply Chain, Drug Discovery, Medical Imaging And Diagnostics, Precision Medicine

5) By End-Users: Manufacturers, Contract Research Organizations, Academic And Government Research Institutes

Subsegments:

1) By Hardware: High-Performance Computing Systems, AI-Enabled Laboratory Equipment, Data Storage Solutions

2) By Software: Drug Discovery Platforms, Clinical Trial Management Software, Predictive Analytics Tools, Natural Language Processing Solutions

3) By Services: Consulting Services, Implementation And Integration Services, Data Management And Analytics Services, Training And Support Services

Which Regions Are Setting the Pace for Artificial Intelligence (AI) In Biopharmaceuticals Market Growth?

North America was the largest region in the artificial intelligence (AI) in biopharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in biopharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Defining Features of the Artificial Intelligence (AI) In Biopharmaceuticals Market?

Artificial intelligence (AI) in biopharmaceuticals refers to applying various AI techniques to analyze complex biological data and improve various aspects of drug discovery, development, and delivery within the pharmaceutical industry. AI in biopharmaceuticals holds great promise for revolutionizing drug discovery, development, and delivery processes by accelerating timelines, reducing costs, and improving the efficiency and effectiveness of treatments.

Browse Through More Similar Reports By The Business Research Company:

Artificial Intelligence in Healthcare Diagnosis Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-healthcare-diagnosis-global-market-report

Artificial Intelligence (AI) In Industrial Machinery Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-industrial-machinery-global-market-report

Artificial Intelligence (AI) in Operating Room Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-operating-room-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: